608 related articles for article (PubMed ID: 29959908)
1. MANF protects dopamine neurons and locomotion defects from a human α-synuclein induced Parkinson's disease model in C. elegans by regulating ER stress and autophagy pathways.
Zhang Z; Shen Y; Luo H; Zhang F; Peng D; Jing L; Wu Y; Xia X; Song Y; Li W; Jin L
Exp Neurol; 2018 Oct; 308():59-71. PubMed ID: 29959908
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic potential of the endoplasmic reticulum located and secreted CDNF/MANF family of neurotrophic factors in Parkinson's disease.
Voutilainen MH; Arumäe U; Airavaara M; Saarma M
FEBS Lett; 2015 Dec; 589(24 Pt A):3739-48. PubMed ID: 26450777
[TBL] [Abstract][Full Text] [Related]
3. MANF Inhibits
Zhang JX; Tong WF; Jiang M; Zhou KG; Xiang XR; He YJ; Zhang ZY; Guan Q; Jin LJ
Oxid Med Cell Longev; 2022; 2022():7925686. PubMed ID: 35847585
[TBL] [Abstract][Full Text] [Related]
4. Diterpene glycosides from Holothuria scabra exert the α-synuclein degradation and neuroprotection against α-synuclein-Mediated neurodegeneration in C. elegans model.
Chalorak P; Sornkaew N; Manohong P; Niamnont N; Malaiwong N; Limboonreung T; Sobhon P; Aschner M; Meemon K
J Ethnopharmacol; 2021 Oct; 279():114347. PubMed ID: 34147616
[TBL] [Abstract][Full Text] [Related]
5. The Bcl-2 homologue Buffy rescues α-synuclein-induced Parkinson disease-like phenotypes in Drosophila.
M'Angale PG; Staveley BE
BMC Neurosci; 2016 May; 17(1):24. PubMed ID: 27192974
[TBL] [Abstract][Full Text] [Related]
6. VPS35 in Dopamine Neurons Is Required for Endosome-to-Golgi Retrieval of Lamp2a, a Receptor of Chaperone-Mediated Autophagy That Is Critical for α-Synuclein Degradation and Prevention of Pathogenesis of Parkinson's Disease.
Tang FL; Erion JR; Tian Y; Liu W; Yin DM; Ye J; Tang B; Mei L; Xiong WC
J Neurosci; 2015 Jul; 35(29):10613-28. PubMed ID: 26203154
[TBL] [Abstract][Full Text] [Related]
7. Enhanced ubiquitin-dependent degradation by Nedd4 protects against α-synuclein accumulation and toxicity in animal models of Parkinson's disease.
Davies SE; Hallett PJ; Moens T; Smith G; Mangano E; Kim HT; Goldberg AL; Liu JL; Isacson O; Tofaris GK
Neurobiol Dis; 2014 Apr; 64(100):79-87. PubMed ID: 24388974
[TBL] [Abstract][Full Text] [Related]
8. Acetylcorynoline attenuates dopaminergic neuron degeneration and α-synuclein aggregation in animal models of Parkinson's disease.
Fu RH; Wang YC; Chen CS; Tsai RT; Liu SP; Chang WL; Lin HL; Lu CH; Wei JR; Wang ZW; Shyu WC; Lin SZ
Neuropharmacology; 2014 Jul; 82():108-20. PubMed ID: 23973292
[TBL] [Abstract][Full Text] [Related]
9. Mesencephalic astrocyte-derived neurotrophic factor: A treatment option for parkinson's disease.
Yang C; Gao Y
Front Biosci (Landmark Ed); 2020 Jun; 25(9):1718-1731. PubMed ID: 32472754
[TBL] [Abstract][Full Text] [Related]
10. Application of a C. elegans dopamine neuron degeneration assay for the validation of potential Parkinson's disease genes.
Berkowitz LA; Hamamichi S; Knight AL; Harrington AJ; Caldwell GA; Caldwell KA
J Vis Exp; 2008 Jul; (17):. PubMed ID: 19066512
[TBL] [Abstract][Full Text] [Related]
11. Dendrobine inhibits dopaminergic neuron apoptosis via MANF-mediated ER stress suppression in MPTP/MPP
Li QM; Li X; Su SQ; Wang YT; Xu T; Zha XQ; Pan LH; Shang ZZ; Zhang FY; Luo JP
Phytomedicine; 2022 Jul; 102():154193. PubMed ID: 35636177
[TBL] [Abstract][Full Text] [Related]
12. Osmotic stress induced toxicity exacerbates Parkinson's associated effects via dysregulation of autophagy in transgenic C. elegans model.
Jadiya P; Mir SS; Nazir A
Cell Signal; 2018 May; 45():71-80. PubMed ID: 29410282
[TBL] [Abstract][Full Text] [Related]
13. The usual suspects, dopamine and alpha-synuclein, conspire to cause neurodegeneration.
Mor DE; Daniels MJ; Ischiropoulos H
Mov Disord; 2019 Feb; 34(2):167-179. PubMed ID: 30633814
[TBL] [Abstract][Full Text] [Related]
14. Current disease modifying approaches to treat Parkinson's disease.
Lindholm D; Mäkelä J; Di Liberto V; Mudò G; Belluardo N; Eriksson O; Saarma M
Cell Mol Life Sci; 2016 Apr; 73(7):1365-79. PubMed ID: 26616211
[TBL] [Abstract][Full Text] [Related]
15. Long-term protective effects of AAV9-mesencephalic astrocyte-derived neurotrophic factor gene transfer in parkinsonian rats.
Hao F; Yang C; Chen SS; Wang YY; Zhou W; Hao Q; Lu T; Hoffer B; Zhao LR; Duan WM; Xu QY
Exp Neurol; 2017 May; 291():120-133. PubMed ID: 28131727
[TBL] [Abstract][Full Text] [Related]
16. α-Synuclein accumulation and GBA deficiency due to L444P GBA mutation contributes to MPTP-induced parkinsonism.
Yun SP; Kim D; Kim S; Kim S; Karuppagounder SS; Kwon SH; Lee S; Kam TI; Lee S; Ham S; Park JH; Dawson VL; Dawson TM; Lee Y; Ko HS
Mol Neurodegener; 2018 Jan; 13(1):1. PubMed ID: 29310663
[TBL] [Abstract][Full Text] [Related]
17. A Systematic RNAi Screen of Neuroprotective Genes Identifies Novel Modulators of Alpha-Synuclein-Associated Effects in Transgenic Caenorhabditis elegans.
Jadiya P; Fatima S; Baghel T; Mir SS; Nazir A
Mol Neurobiol; 2016 Nov; 53(9):6288-6300. PubMed ID: 26567108
[TBL] [Abstract][Full Text] [Related]
18. Mesencephalic astrocyte-derived neurotrophic factor reduces cell apoptosis via upregulating GRP78 in SH-SY5Y cells.
Huang J; Chen C; Gu H; Li C; Fu X; Jiang M; Sun H; Xu J; Fang J; Jin L
Cell Biol Int; 2016 Jul; 40(7):803-11. PubMed ID: 27145383
[TBL] [Abstract][Full Text] [Related]
19. MANF: a new mesencephalic, astrocyte-derived neurotrophic factor with selectivity for dopaminergic neurons.
Petrova P; Raibekas A; Pevsner J; Vigo N; Anafi M; Moore MK; Peaire AE; Shridhar V; Smith DI; Kelly J; Durocher Y; Commissiong JW
J Mol Neurosci; 2003 Apr; 20(2):173-88. PubMed ID: 12794311
[TBL] [Abstract][Full Text] [Related]
20. Parkinson's disease-associated
Mori A; Hatano T; Inoshita T; Shiba-Fukushima K; Koinuma T; Meng H; Kubo SI; Spratt S; Cui C; Yamashita C; Miki Y; Yamamoto K; Hirabayashi T; Murakami M; Takahashi Y; Shindou H; Nonaka T; Hasegawa M; Okuzumi A; Imai Y; Hattori N
Proc Natl Acad Sci U S A; 2019 Oct; 116(41):20689-20699. PubMed ID: 31548400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
